NCT00306891View on ClinicalTrials.gov

Effect of Food Upon Pharmacokinetics of Single Oral Dose of Cediranib (AZD2171, Recentin™)

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

January 31, 2008

Study Completion Date

September 30, 2008

Conditions
Cancer
Interventions
DRUG

Cediranib

45 mg oral dose

DRUG

Cediranib 30 - 90 mg

oral tablet dose escalation

Trial Locations (4)

Unknown

Research Site, Glasgow

Research Site, Headington

Research Site, London

Research Site, Manchester

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY